Characterization of the KRas G12D-inhibitor interactions by differential HDX-MS and molecular dynamics simulations

Evgeniy V Petrotchenko1, Brandon Novy2, Edith Nagy3

  • 1Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

Abstract